{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:13:45Z","timestamp":1790802825210,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s40119-020-00202-6","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T19:02:46Z","timestamp":1606503766000},"page":"161-173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Trimetazidine and Bisoprolol to Treat Angina in Symptomatic Patients: Post Hoc Analysis From the CHOICE-2 Study"],"prefix":"10.1007","volume":"10","author":[{"name":"on behalf of the CHOICE-2 study investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Glezer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,27]]},"reference":[{"key":"202_CR1","doi-asserted-by":"crossref","unstructured":"GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151\u2013210.","DOI":"10.1016\/S0140-6736(17)32152-9"},{"issue":"16","key":"202_CR2","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/eurheartj\/ehm198","volume":"28","author":"PA Poole-Wilson","year":"2007","unstructured":"Poole-Wilson PA, Voko Z, Kirwan BA, de Brouwer S, Dunselman PH, Lubsen J. Clinical course of isolated stable angina due to coronary heart disease. Eur Heart J. 2007;28(16):1928\u201335.","journal-title":"Eur Heart J"},{"key":"202_CR3","doi-asserted-by":"crossref","unstructured":"Povsic TJ, Broderick S, Anstrom KJ, et al. Predictors of long-term clinical endpoints in patients with refractory angina. J Am Heart Assoc. 2015;4(2):e001287.","DOI":"10.1161\/JAHA.114.001287"},{"issue":"25","key":"202_CR4","first-page":"e354","volume":"126","author":"SD Fihn","year":"2012","unstructured":"Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126(25):e354-471.","journal-title":"Circulation"},{"issue":"8","key":"202_CR5","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1177\/2047487314547652","volume":"22","author":"R Ferrari","year":"2015","unstructured":"Ferrari R, Ford I, Greenlaw N, et al. Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: data from the contemporary CLARIFY registry. Eur J Prev Cardiol. 2015;22(8):1056\u201365.","journal-title":"Eur J Prev Cardiol"},{"issue":"10","key":"202_CR6","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1001\/jamainternmed.2014.3773","volume":"174","author":"PG Steg","year":"2014","unstructured":"Steg PG, Greenlaw N, Tendera M, et al. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry. JAMA Intern Med. 2014;174(10):1651\u20139.","journal-title":"JAMA Intern Med"},{"key":"202_CR7","doi-asserted-by":"crossref","unstructured":"Huqi A, Morrone D, Guarini G, Capozza P, Orsini E, Marzilli M (2016) Stress testing after complete and successful coronary revascularization. Can J Cardiol 32(8):986.e23\u20139.","DOI":"10.1016\/j.cjca.2015.12.025"},{"key":"202_CR8","doi-asserted-by":"crossref","unstructured":"Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360(3):213\u201324.","DOI":"10.1056\/NEJMoa0807611"},{"issue":"8","key":"202_CR9","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.amjcard.2009.05.056","volume":"104","author":"DJ Maron","year":"2009","unstructured":"Maron DJ, Spertus JA, Mancini GB, et al. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial. Am J Cardiol. 2009;104(8):1055\u201362.","journal-title":"Am J Cardiol"},{"issue":"5","key":"202_CR10","doi-asserted-by":"publisher","first-page":"e36284","DOI":"10.1371\/journal.pone.0036284","volume":"7","author":"PG Steg","year":"2012","unstructured":"Steg PG, Ferrari R, Ford I, et al. Heart rate and use of beta-blockers in stable outpatients with coronary artery disease. PLoS ONE. 2012;7(5):e36284.","journal-title":"PLoS ONE"},{"issue":"5","key":"202_CR11","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/01.RES.86.5.580","volume":"86","author":"PF Kantor","year":"2000","unstructured":"Kantor PF, Lucien A, Kozak R, Lopaschuk GD. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res. 2000;86(5):580\u20138.","journal-title":"Circ Res"},{"issue":"8","key":"202_CR12","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/eurheartj\/ehi816","volume":"27","author":"G Fragasso","year":"2006","unstructured":"Fragasso G, Perseghin G, De Cobelli F, et al. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine\/adenosine triphosphate ratio in patients with heart failure. Eur Heart J. 2006;27(8):942\u20138.","journal-title":"Eur Heart J"},{"issue":"Suppl 4","key":"202_CR13","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/BF00051292","volume":"4","author":"S Dalla-Volta","year":"1990","unstructured":"Dalla-Volta S, Maraglino G, Della-Valentina P, Viena P, Desideri A. Comparison of trimetazidine with nifedipine in effort angina: a double-blind, crossover study. Cardiovasc Drugs Ther. 1990;4(Suppl 4):853\u20139.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"24","key":"202_CR14","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1053\/euhj.2001.2896","volume":"22","author":"H Szwed","year":"2001","unstructured":"Szwed H, Sadowski Z, Elikowski W, et al. Combination treatment in stable effort angina using trimetazidine and metoprolol. Results of a randomized, double-blind, multicentre study (TRIMPOL II). Eur Heart J. 2001;22(24):2267\u201374.","journal-title":"Eur Heart J"},{"issue":"3","key":"202_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1365-2125.1994.tb04276.x","volume":"37","author":"JM Detry","year":"1994","unstructured":"Detry JM, Sellier P, Pennaforte S, Cokkinos D, Dargie H, Mathes P. Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group. Br J Clin Pharmacol. 1994;37(3):279\u201388.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"202_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/clc.20888","volume":"34","author":"B Hu","year":"2011","unstructured":"Hu B, Li W, Xu T, Chen T, Guo J. Evaluation of trimetazidine in angina pectoris by echocardiography and radionuclide angiography: a meta-analysis of randomized, controlled trials. Clin Cardiol. 2011;34(6):395\u2013400.","journal-title":"Clin Cardiol"},{"issue":"2","key":"202_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000332369","volume":"120","author":"N Danchin","year":"2011","unstructured":"Danchin N, Marzilli M, Parkhomenko A, Ribeiro JP. Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis. Cardiology. 2011;120(2):59\u201372.","journal-title":"Cardiology"},{"issue":"6","key":"202_CR18","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s00059-015-4392-2","volume":"41","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Peng L, Luo Y, et al. Trimetazidine improves exercise tolerance in patients with ischemic heart disease: a meta-analysis. Herz. 2016;41(6):514\u201322.","journal-title":"Herz"},{"issue":"4","key":"202_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/hrt.2010.208751","volume":"97","author":"D Gao","year":"2011","unstructured":"Gao D, Ning N, Niu X, Hao G, Meng Z. Trimetazidine: a meta-analysis of randomised controlled trials in heart failure. Heart. 2011;97(4):278\u201386.","journal-title":"Heart"},{"issue":"10","key":"202_CR20","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jacc.2011.11.027","volume":"59","author":"L Zhang","year":"2012","unstructured":"Zhang L, Lu Y, Jiang H, et al. Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis. J Am Coll Cardiol. 2012;59(10):913\u201322.","journal-title":"J Am Coll Cardiol."},{"issue":"5","key":"202_CR21","doi-asserted-by":"publisher","first-page":"e94660","DOI":"10.1371\/journal.pone.0094660","volume":"9","author":"X Zhou","year":"2014","unstructured":"Zhou X, Chen J. Is treatment with trimetazidine beneficial in patients with chronic heart failure? PLoS ONE. 2014;9(5):e94660.","journal-title":"PLoS ONE"},{"key":"202_CR22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.ijcard.2015.11.060","volume":"203","author":"YM Lopatin","year":"2016","unstructured":"Lopatin YM, Rosano GM, Fragasso G, et al. Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure. Int J Cardiol. 2016;203:909\u201315.","journal-title":"Int J Cardiol"},{"issue":"1","key":"202_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2165\/00044011-199713010-00002","volume":"13","author":"AP Michaelides","year":"1997","unstructured":"Michaelides AP, Spiropoulos K, Dimopoulos K, Athanasiades D, Toutouzas P. Antianginal efficacy of the combination of trimetazidine-propranolol compared with isosorbide dinitrate-propranolol in patients with stable angina. Clin Drug Invest. 1997;13(1):8\u201314.","journal-title":"Clini Drug Invest"},{"issue":"9","key":"202_CR24","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1185\/030079904X2637","volume":"20","author":"W Ruzyllo","year":"2004","unstructured":"Ruzyllo W, Szwed H, Sadowski Z, et al. Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study. Curr Med Res Opin. 2004;20(9):1447\u201354.","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"202_CR25","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s12325-017-0490-2","volume":"34","author":"M Glezer","year":"2017","unstructured":"Glezer M. Real-world evidence for the antianginal efficacy of trimetazidine from the russian observational CHOICE-2 study. Adv Ther. 2017;34(4):915\u201324.","journal-title":"Adv Ther"},{"issue":"3","key":"202_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/1074248416679733","volume":"22","author":"RA Kloner","year":"2017","unstructured":"Kloner RA, Chaitman B. Angina and Its Management. J Cardiovasc Pharmacol Ther. 2017;22(3):199\u2013209.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"6","key":"202_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.2165\/00003495-200565060-00006","volume":"65","author":"KE Ellison","year":"2005","unstructured":"Ellison KE, Gandhi G. Optimising the use of beta-adrenoceptor antagonists in coronary artery disease. Drugs. 2005;65(6):787\u201397.","journal-title":"Drugs"},{"key":"202_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.phrs.2018.10.031","volume":"139","author":"M Sabido","year":"2019","unstructured":"Sabido M, Thilo H, Guido G. Long-term effectiveness of bisoprolol in patients with angina: a real-world evidence study. Pharmacol Res. 2019;139:106\u201312.","journal-title":"Pharmacol Res"},{"key":"202_CR29","unstructured":"European Society of Cardiology (ESC). 2019 Guidelines on chronic coronary syndromes. ESC clinical practice guidelines 2019. https:\/\/www.escardio.org\/Guidelines\/Clinical-Practice-Guidelines\/Chronic-Coronary-Syndromes."},{"issue":"1","key":"202_CR30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijcard.2014.06.052","volume":"176","author":"M Tendera","year":"2014","unstructured":"Tendera M, Fox K, Ferrari R, et al. Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry. Int J Cardiol. 2014;176(1):119\u201324.","journal-title":"Int J Cardiol"},{"issue":"1","key":"202_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0167-5273(83)90058-X","volume":"3","author":"RM Boyle","year":"1983","unstructured":"Boyle RM, Bray CL, Naqvi N, Croxson RS, Cruickshank JM. A comparison of once and twice daily atenolol for angina pectoris. Int J Cardiol. 1983;3(1):25\u201335.","journal-title":"Int J Cardiol"},{"issue":"10","key":"202_CR32","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1093\/eurheartj\/ehi705","volume":"27","author":"GH Gislason","year":"2006","unstructured":"Gislason GH, Rasmussen JN, Abildstrom SZ, et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J. 2006;27(10):1153\u20138.","journal-title":"Eur Heart J."},{"issue":"10115","key":"202_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","volume":"391","author":"R Al-Lamee","year":"2018","unstructured":"Al-Lamee R, Thompson D, Dehbi H-M, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018;391(10115):31\u201340.","journal-title":"Lancet"},{"issue":"3","key":"202_CR34","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.ijcard.2014.10.149","volume":"177","author":"S Peng","year":"2014","unstructured":"Peng S, Zhao M, Wan J, Fang Q, Fang D, Li K. The efficacy of trimetazidine on stable angina pectoris: a meta-analysis of randomized clinical trials. Int J Cardiol. 2014;177(3):780\u20135.","journal-title":"Int J Cardiol."},{"issue":"15","key":"202_CR35","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa070829","volume":"356","author":"WE Boden","year":"2007","unstructured":"Boden WE, O\u2019Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503\u201316.","journal-title":"N Engl J Med."},{"issue":"10014","key":"202_CR36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0140-6736(15)00459-6","volume":"387","author":"G Weisz","year":"2016","unstructured":"Weisz G, Genereux P, Iniguez A, et al. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2016;387(10014):136\u201345.","journal-title":"Lancet"},{"issue":"11","key":"202_CR37","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jacc.2018.05.075","volume":"72","author":"PA Peri-Okonny","year":"2018","unstructured":"Peri-Okonny PA, Patel KK, Jones PG, et al. Low diastolic blood pressure is associated with angina in patients with chronic coronary artery disease. J Am Coll Cardiol. 2018;72(11):1227\u201332.","journal-title":"J Am Coll Cardiol."},{"issue":"1","key":"202_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/HYPERTENSIONAHA.117.10204","volume":"71","author":"E Vidal-Petiot","year":"2018","unstructured":"Vidal-Petiot E, Greenlaw N, Ford I, et al. Relationships between components of blood pressure and cardiovascular events in patients with stable coronary artery disease and hypertension. Hypertension. 2018;71(1):168\u201376.","journal-title":"Hypertension"}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-020-00202-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-020-00202-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-020-00202-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T03:43:21Z","timestamp":1621223001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40119-020-00202-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,27]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["202"],"URL":"https:\/\/doi.org\/10.1007\/s40119-020-00202-6","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"value":"2193-8261","type":"print"},{"value":"2193-6544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,27]]},"assertion":[{"value":"23 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}